Diferansiye tiroit kanserlerinin takibinde tiroglobulin otoantikorunun önemi

Kgün A; Yazıcı B; Erdim Ö; Yararbaş Ü; Özkılıç H

EN TR

The use of TgAb as a marker in differentiated thyroid cancer after ablation theraphy

Abstract

Introduction: Aim was to evaluate thyroglobulin antibodies (TgAbs) variations before and after ablation and correlate thyroglobulin (Tg) and TgAbs levels to the outcome of disease in differentiated thyroid carcinoma (DTC) Material and Methods: We focused on 27 patients (22 female, 5 male, age range 24-70 years, 25 papillary and 2 follicular carcinoma) who had high levels of TgAbs in the post-surgical period. The follow-up was ranging form 30 to 88 months (mean: 45±16 months). The amount of I-131 administered was 75-175 mCi (mean 104.63±20,84 mCi ) Results: Successful ablation was achieved in 25 of 27 (92.5 %) patients. When pre and post ablation values were compared TgAb and Tg levels regressed significantly (Tg 1.66±3.70 ng/ml 0.19±0.25 ng/ml p

Keywords

Thyroglobulin, differentiated thyroid carcinoma, thyroglobulin autoantibody

Details

Primary Language

Turkish

Subjects

-

Journal Section

-

Authors

Kgün A

Yazıcı B

Erdim Ö

Yararbaş Ü

Özkılıç H

Publication Date

March 1, 2009

Submission Date

March 1, 2009

Acceptance Date

-

Published in Issue

Year 1970 Volume: 48 Number: 1

IZ

https://izlik.org/JA49CC93KW

Cite

RIS / Bibtex

Vancouver

1.Kgün A, Yazıcı B, Erdim Ö, Yararbaş Ü, Özkılıç H. Diferansiye tiroit kanserlerinin takibinde tiroglobulin otoantikorunun önemi. EJM [Internet]. 2009 Mar. 1;48(1):19-22. Available from: https://izlik.org/JA49CC93KW

The use of TgAb as a marker in differentiated thyroid cancer after ablation theraphy

Abstract

Keywords